ALBANY, N.Y., Oct. 11, 2019 /PRNewswire/ -- Glauconix Biosciences, Inc., a specialty pharmaceutical company that uses its patented platform technology to develop human 3D ocular tissues that mimic the fluid dynamics in the eye to expedite and de-risk the R&D of ophthalmic treatments,...
from PR Newswire: https://ift.tt/2IGa8uW
No comments:
Post a Comment